IL135584A - Use of dual, non-selective antagonists ß-adrenoreceptor and α1-adrenoreceptor in the preparation of a drug for the treatment of amyloid diseases - Google Patents
Use of dual, non-selective antagonists ß-adrenoreceptor and α1-adrenoreceptor in the preparation of a drug for the treatment of amyloid diseasesInfo
- Publication number
- IL135584A IL135584A IL13558498A IL13558498A IL135584A IL 135584 A IL135584 A IL 135584A IL 13558498 A IL13558498 A IL 13558498A IL 13558498 A IL13558498 A IL 13558498A IL 135584 A IL135584 A IL 135584A
- Authority
- IL
- Israel
- Prior art keywords
- carbon atoms
- hydrogen
- adrenoceptor
- lower alkyl
- selective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6236697P | 1997-10-15 | 1997-10-15 | |
PCT/US1998/021789 WO1999018794A1 (en) | 1997-10-15 | 1998-10-15 | Method for treating alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
IL135584A0 IL135584A0 (en) | 2001-05-20 |
IL135584A true IL135584A (en) | 2005-12-18 |
Family
ID=22042015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13558498A IL135584A (en) | 1997-10-15 | 1998-10-15 | Use of dual, non-selective antagonists ß-adrenoreceptor and α1-adrenoreceptor in the preparation of a drug for the treatment of amyloid diseases |
Country Status (16)
Country | Link |
---|---|
US (1) | US6358990B1 (ko) |
EP (1) | EP1024697A4 (ko) |
JP (1) | JP2001519364A (ko) |
KR (1) | KR100573352B1 (ko) |
CN (1) | CN1281334A (ko) |
AU (1) | AU751526B2 (ko) |
BR (1) | BR9814075A (ko) |
CA (1) | CA2305262A1 (ko) |
HU (1) | HUP0100024A3 (ko) |
IL (1) | IL135584A (ko) |
NO (1) | NO20001869L (ko) |
NZ (1) | NZ504419A (ko) |
PL (1) | PL339910A1 (ko) |
TR (1) | TR200001018T2 (ko) |
WO (1) | WO1999018794A1 (ko) |
ZA (1) | ZA989365B (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10142175A1 (de) * | 2001-10-09 | 2003-03-27 | Eucro Europe Contract Res Gmbh | Verwendung von ß-Adrenozeptor-Agonisten zur Behandlung von neurodegenerativen Erkrankungen |
US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
WO2003092622A2 (en) * | 2002-04-30 | 2003-11-13 | Sb Pharmco Puerto Rico Inc. | Carvedilol monocitrate monohydrate |
EP1539140A4 (en) * | 2002-06-27 | 2005-12-07 | Sb Pharmco Inc | CARVEDILOLHYDOBROMID |
BR0312102A (pt) * | 2002-06-27 | 2007-05-29 | Sb Pharmco Inc | sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento |
US20050169994A1 (en) * | 2003-11-25 | 2005-08-04 | Burke Matthew D. | Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
JP2007512372A (ja) * | 2003-11-25 | 2007-05-17 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | カルベジロール塩、対応する組成物、送達および/または治療方法 |
US8734850B2 (en) * | 2003-11-25 | 2014-05-27 | Flamel Technologies | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form |
CN1991364A (zh) * | 2005-12-26 | 2007-07-04 | 中国科学院上海生命科学研究院 | 预防和治疗阿尔兹海默症的g蛋白偶联受体拮抗剂 |
WO2007112288A2 (en) * | 2006-03-23 | 2007-10-04 | Mount Sinai School Of Medicine | Cardiovascular composition and use the same for the treatment of alzheimers disease |
WO2008021552A2 (en) * | 2006-08-18 | 2008-02-21 | Duke University | Biased ligands and methods of identifying same |
US20090076116A1 (en) * | 2007-09-13 | 2009-03-19 | Protia, Llc | Deuterium-enriched carvediolo |
DK2247558T3 (da) | 2008-02-14 | 2022-02-21 | Lilly Co Eli | Nye billeddannelsesmidler til detektering af neurologisk dysfunktion |
US8932557B2 (en) | 2008-02-14 | 2015-01-13 | Eli Lilly And Company | Imaging agents for detecting neurological dysfunction |
CN103172643B (zh) * | 2011-12-26 | 2016-03-02 | 中国医学科学院药物研究所 | 黄皮咔唑生物碱及其制备方法和其药物组合物与用途 |
CN102816107B (zh) * | 2012-08-20 | 2015-06-03 | 东南大学 | 咔唑衍生物及其制备方法与用途 |
EP3013342B1 (en) | 2013-06-27 | 2021-04-14 | Cedars-Sinai Medical Center | Adrenoceptors antagonists for the prevention and treatment of neurodegenerative conditions |
US20230381139A1 (en) * | 2020-09-17 | 2023-11-30 | Uti Limited Partnership | Methods of treating and/or preventing alzheimer’s disease with r-carvedilol |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3319027A1 (de) * | 1983-05-26 | 1984-11-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten |
PH25025A (en) * | 1986-12-17 | 1991-01-28 | Glaxo Group Ltd | A method of treating dementia and other cognitive disorders using 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one |
US4868190A (en) * | 1988-12-27 | 1989-09-19 | Hoechst-Roussel Pharmaceuticals, Inc. | N-pyridinyl-9H-carbazol-9-amines |
US4983608A (en) * | 1989-09-05 | 1991-01-08 | Hoechst-Roussell Pharmaceuticals, Inc. | N-substituted-4-pyrimidinamines and pyrimidinediamines |
JPH0558998A (ja) * | 1991-09-06 | 1993-03-09 | Taisho Pharmaceut Co Ltd | カルバゾール誘導体 |
CN1166169A (zh) * | 1994-07-27 | 1997-11-26 | 三共株式会社 | 用作毒蕈碱性受体别构效应物的杂环化合物 |
FR2724933A1 (fr) * | 1994-09-22 | 1996-03-29 | Pf Medicament | Nouveaux ethers aromatiques derives d'indoles utiles comme medicaments |
US5760069A (en) * | 1995-02-08 | 1998-06-02 | Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 | Method of treatment for decreasing mortality resulting from congestive heart failure |
FR2731222A1 (fr) * | 1995-03-02 | 1996-09-06 | Pf Medicament | Nouveaux derives de piperazine aminoindoles cycliques, leur procede de preparation et leur utilisation a titre de medicaments |
EP1110945A3 (en) * | 1995-05-01 | 2003-05-07 | University Of Pittsburgh | Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
-
1998
- 1998-10-14 ZA ZA989365A patent/ZA989365B/xx unknown
- 1998-10-15 US US09/529,526 patent/US6358990B1/en not_active Expired - Fee Related
- 1998-10-15 TR TR2000/01018T patent/TR200001018T2/xx unknown
- 1998-10-15 PL PL98339910A patent/PL339910A1/xx unknown
- 1998-10-15 WO PCT/US1998/021789 patent/WO1999018794A1/en not_active Application Discontinuation
- 1998-10-15 JP JP2000515438A patent/JP2001519364A/ja active Pending
- 1998-10-15 CN CN98812171A patent/CN1281334A/zh active Pending
- 1998-10-15 CA CA002305262A patent/CA2305262A1/en not_active Abandoned
- 1998-10-15 IL IL13558498A patent/IL135584A/en not_active IP Right Cessation
- 1998-10-15 AU AU10897/99A patent/AU751526B2/en not_active Ceased
- 1998-10-15 EP EP98953558A patent/EP1024697A4/en not_active Withdrawn
- 1998-10-15 BR BR9814075-2A patent/BR9814075A/pt not_active IP Right Cessation
- 1998-10-15 HU HU0100024A patent/HUP0100024A3/hu unknown
- 1998-10-15 NZ NZ504419A patent/NZ504419A/xx unknown
- 1998-10-15 KR KR1020007003990A patent/KR100573352B1/ko not_active IP Right Cessation
-
2000
- 2000-04-11 NO NO20001869A patent/NO20001869L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NZ504419A (en) | 2002-11-26 |
TR200001018T2 (tr) | 2000-08-21 |
JP2001519364A (ja) | 2001-10-23 |
ZA989365B (en) | 1999-04-15 |
CN1281334A (zh) | 2001-01-24 |
EP1024697A1 (en) | 2000-08-09 |
AU1089799A (en) | 1999-05-03 |
KR100573352B1 (ko) | 2006-04-25 |
WO1999018794A1 (en) | 1999-04-22 |
EP1024697A4 (en) | 2007-05-02 |
NO20001869L (no) | 2000-06-14 |
CA2305262A1 (en) | 1999-04-22 |
HUP0100024A3 (en) | 2002-12-28 |
KR20010031108A (ko) | 2001-04-16 |
US6358990B1 (en) | 2002-03-19 |
BR9814075A (pt) | 2000-09-26 |
IL135584A0 (en) | 2001-05-20 |
HUP0100024A2 (hu) | 2001-07-30 |
PL339910A1 (en) | 2001-01-15 |
AU751526B2 (en) | 2002-08-22 |
NO20001869D0 (no) | 2000-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU751526B2 (en) | Method for treating Alzheimer's disease | |
KR100386229B1 (ko) | 히드록시카르바졸화합물의평활근유주및증식의억제 | |
US7786174B2 (en) | Methods and compounds for inhibiting amyloid deposits | |
US11325904B2 (en) | Tropinol esters and related compounds to promote normal processing of APP | |
NO20171934A1 (en) | Compositions and methods of treating a neurodegenerative disease | |
JP2002226401A (ja) | うつ病の併用療法 | |
JP4415075B2 (ja) | 炎症性腸疾患のためのカッパーアヘン製剤作働薬 | |
AU2018220521A1 (en) | Compounds and methods for treatment of primary biliary cholangitis | |
US5945448A (en) | Brain edema inhibitor | |
US6096777A (en) | Method for inhibiting the expression of Fas | |
CA2557758C (en) | Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder | |
MXPA00003770A (en) | Method for treating alzheimer's disease | |
US20090253765A1 (en) | Angiogenesis Inhibitor Containing Amine Derivative as Active Ingredient | |
CZ20001310A3 (cs) | Lék pro léčbu onemocnění způsobených amyloidem | |
JP2004262812A (ja) | 眼圧低下剤 | |
WO2020203822A1 (ja) | 血管新生を伴う網膜疾患の治療又は予防のための併用医薬 | |
AU2016333995A1 (en) | Methods for treating synovial sarcoma | |
JP2000007568A (ja) | 神経栄養因子様作用剤 | |
JP2003113085A (ja) | 神経栄養因子様作用剤 | |
JPH09316002A (ja) | 眼疾患用薬剤 | |
JPWO2010047369A1 (ja) | 糖尿病性腎症の治療剤 | |
MXPA99001774A (en) | Method for inhibiting the expression of fas | |
AU3512701A (en) | Method for inhibiting the expression of FAS | |
AU2008229759A1 (en) | Methods and compounds for inhibiting amyloid deposits | |
JP2005154320A (ja) | 眼疾患治療薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |